PDE1A and pulmonary arterial hypertension: In summary, the current study highlighted that BMSC-EVs might deliver miR-200b to alveolar macrophages to inhibit PDE1A and induce PKA phosphorylation, thereby promoting macrophage M2 polarization and ultimately preventing PAH formation (Fig. 8).